About
Technology
Issues
FAQ
Links
Official Page
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.